Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

ABCB6

ATP binding cassette subfamily B member 6 (LAN blood group)

translation score 0.65, read 2026-10-26; 1 sealed predictions, 0 held; 1 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.01 from other evidence0.00
cell type
Human Protein Atlas
group enriched in other brain neurons (21 nCPM)1.00
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
no papers tie it to Parkinson's yet1.00
pathways
Reactome
2 pathways; mostly mitochondrial quality control1.00
proposal for ABCB6, translation score 0.65

Knock down and overexpress ABCB6 in dopamine neurons; measure PINK1–parkin mitophagy flux (mt-Keima) and phospho-ubiquitin (pS65-Ub) and survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils.

Cell type
dopamine neurons
Direction
Both arms: public data does not say which way helps.
Molecular readout
PINK1–parkin mitophagy flux (mt-Keima) and phospho-ubiquitin (pS65-Ub)
Functional readout
survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils
Rule-out
If neither arm moves PINK1–parkin mitophagy flux (mt-Keima) by 20% or more against non-targeting and empty-vector controls, across three independent differentiations, the hypothesis is wrong.
Lab request
CRISPRi knockdown and lentiviral overexpression of ABCB6 in iPSC-derived midbrain dopamine neurons (FOXA2+, LMX1A+, TH+); n = 3 differentiations; readouts: PINK1–parkin mitophagy flux (mt-Keima) and phospho-ubiquitin (pS65-Ub); survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils. Controls: non-targeting guide, empty vector. About 8 to 10 weeks, most of it differentiation.

Sealed predictions

  1. ABCB6 in dopamine neurons, braak-0.43 (p 0.244) → -0.10 (p 0.802)receipt 11316

Swarm cases

receipt 11316: ABCB6 in dopamine neurons, braak

power
full sample -0.32 (p 0.201, n 18), 95% CI -0.68 to +0.18. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.33 (p 0.188, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.35 (p 0.156, n 18). could be the mix.
skeptic
leave-one-out range -0.47 to -0.23, sign flips 0; without severely affected donors -0.32 (p 0.201, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for ABCB6 in dopamine neurons.

case closed: nothing better to follow up.

Receipts

loading the receipts